Spinout https://www.bioworld.com/rss en-us Longaevus Technologies spins off Elastin Biosciences with focus on elastin-deficiency diseases http://www.bioworld.com/articles/700565 Fri, 01 Sep 2023 09:00:00 -0400 https://www.bioworld.com/articles/700565-longaevus-technologies-spins-off-elastin-biosciences-with-focus-on-elastin-deficiency-diseases Heart scientific overlay Emris Pharma to develop topical drug to treat skin toxicities caused by EGFR inhibitor use in cancer http://www.bioworld.com/articles/697806 Fri, 09 Jun 2023 09:00:00 -0400 https://www.bioworld.com/articles/697806-emris-pharma-to-develop-topical-drug-to-treat-skin-toxicities-caused-by-egfr-inhibitor-use-in-cancer The epidermal growth factor receptor in the inactive (left) and active (right) form. Ampersand Biomedicines set to develop programmable, more targeted therapeutics http://www.bioworld.com/articles/694909 Wed, 08 Mar 2023 09:00:00 -0500 https://www.bioworld.com/articles/694909-ampersand-biomedicines-set-to-develop-programmable-more-targeted-therapeutics J&J splits off consumer health division http://www.bioworld.com/articles/513344 Fri, 12 Nov 2021 13:00:00 -0500 https://www.bioworld.com/articles/513344-j-and-j-splits-off-consumer-health-division Two arrows in opposite directions Evotec draws $34M in VC funding for DDR-focused spin-out firm Breakpoint http://www.bioworld.com/articles/389726 Tue, 09 Jul 2019 00:00:00 -0400 https://www.bioworld.com/articles/389726-evotec-draws-34m-in-vc-funding-for-ddr-focused-spin-out-firm-breakpoint